Indegene Limited (NSE:INDGN)
India · Delayed Price · Currency is INR 474.70
+3.95 (0.84%)
At close: Feb 13, 2026
Indegene Revenue
Indegene had revenue of 9.42B INR in the quarter ending December 31, 2025, with 30.77% growth. This brings the company's revenue in the last twelve months to 32.63B, up 18.36% year-over-year. In the fiscal year ending March 31, 2025, Indegene had annual revenue of 28.39B with 9.64% growth.
Revenue (ttm)
32.63B
Revenue Growth
+18.36%
P/S Ratio
3.49
Revenue / Employee
7.85M
Employees
4,158
Market Cap
113.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 28.39B | 2.50B | 9.64% |
| Mar 31, 2024 | 25.90B | 2.84B | 12.29% |
| Mar 31, 2023 | 23.06B | 6.41B | 38.54% |
| Mar 31, 2022 | 16.65B | 6.84B | 69.76% |
| Mar 31, 2021 | 9.81B | 3.37B | 52.36% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| MedPlus Health Services | 65.38B |
| Alivus Life Sciences | 25.12B |
| Rainbow Children's Medicare | 16.13B |
| Metropolis Healthcare | 15.66B |